Revenue growth of roughly 16% to 20% year over year and an 80% to 86% gross margin band suggest healthy demand, but operating margin of 18.0% in 2026Q3 versus 5.8% in 2026Q2 indicates volatile profitability and limited operating leverage given SG&A of $57.8M to $62.3M in recent quarters.
Cellebrite DI Ltd. (CLBT) annual income statement — 7-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 |
|---|
| Sales/Revenue | 537.28M | 475.68M | 401.2M | 325.11M | 270.65M | 246.25M | 194.91M | 171.85M |
| Revenue Growth % | 17.85% | 18.56% | 23.41% | 20.12% | 9.91% | 26.34% | 13.42% | - |
| Cost of Goods Sold | 95.29M | 75.17M | 62.59M | 53.23M | 50.75M | 42.56M | 37.88M | 35.82M |
| COGS % of Revenue | - | 15.8% | 15.6% | 16.37% | 18.75% | 17.28% | 19.43% | 20.84% |
| Gross Profit | 441.99M | 400.5M | 338.61M | 271.88M | 219.91M | 203.69M | 157.03M | 136.03M |
| Gross Margin % | 82.26% | 84.2% | 84.4% | 83.63% | 81.25% | 82.72% | 80.57% | 79.16% |
| Gross Profit Growth % | - | 18.28% | 24.54% | 23.63% | 7.96% | 29.71% | 15.44% | - |
| Operating Expenses | 377.56M | 334.02M | 281.7M | 238.64M | 218.86M | 189.87M | 147.82M | 137.55M |
| OpEx % of Revenue | - | 70.22% | 70.21% | 73.4% | 80.86% | 77.1% | 75.84% | 80.04% |
| Selling, General & Admin | 239.48M | 220.15M | 183.29M | 154.26M | 138.24M | 124.33M | 91.17M | 90.23M |
| SG&A % of Revenue | - | 46.28% | 45.68% | 47.45% | 51.08% | 50.49% | 46.77% | 52.5% |
| Research & Development | 138.09M | 113.88M | 98.42M | 84.39M | 80.62M | 65.54M | 54.38M | 46.57M |
| R&D % of Revenue | - | 23.94% | 24.53% | 25.96% | 29.79% | 26.62% | 27.9% | 27.1% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 2.27M | 750K |
| Operating Income | 64.42M | 66.48M | 56.91M | 33.24M | 1.04M | 13.82M | 9.22M | -1.52M |
| Operating Margin % | 11.99% | 13.98% | 14.18% | 10.22% | 0.39% | 5.61% | 4.73% | -0.88% |
| Operating Income Growth % | - | 16.82% | 71.21% | 3083.62% | -92.45% | 49.95% | 706.45% | - |
| EBITDA | 93.63M | 78.35M | 67.51M | 43.25M | 10.24M | 20.83M | 15.1M | 2.56M |
| EBITDA Margin % | 17.43% | 16.47% | 16.83% | 13.3% | 3.78% | 8.46% | 7.75% | 1.49% |
| EBITDA Growth % | 29.93% | 16.05% | 56.11% | 322.43% | -50.85% | 37.97% | 489.96% | - |
| D&A (Non-Cash Add-back) | 29.2M | 11.87M | 10.61M | 10.01M | 9.19M | 7.01M | 5.88M | 4.08M |
| EBIT | 93.66M | 91.2M | -275.95M | -75.42M | 120.91M | 82.46M | 11.4M | 1.54M |
| Net Interest Income | 14.22M | 24.2M | -331.54M | 8.89M | 1.88M | 694K | 1.4M | 3.12M |
| Interest Income | 14.22M | 24.2M | 18.22M | 8.89M | 2.02M | 847K | 2.82M | 3.48M |
| Interest Expense | 0 | 0 | 349.76M | 0 | 149K | 153K | 1.42M | 352K |
| Other Income/Expense | 18.41M | 24.2M | -332.89M | -108.8M | 119.72M | 68.48M | 2.18M | 2.94M |
| Pretax Income | 82.83M | 90.68M | -275.98M | -75.56M | 120.76M | 82.31M | 11.4M | 1.42M |
| Pretax Margin % | 15.42% | 19.06% | -68.79% | -23.24% | 44.62% | 33.42% | 5.85% | 0.82% |
| Income Tax | 17.61M | 12.35M | 7.02M | 5.54M | -45K | 10.91M | 5.62M | 3.29M |
| Effective Tax Rate % | 21.26% | 13.62% | -2.54% | -7.33% | -0.04% | 13.25% | 49.28% | 232.58% |
| Net Income | 65.23M | 78.33M | -283.01M | -81.1M | 120.81M | 71.4M | 5.78M | -1.88M |
| Net Margin % | 12.14% | 16.47% | -70.54% | -24.95% | 44.64% | 28.99% | 2.97% | -1.09% |
| Net Income Growth % | -14.55% | 127.68% | -248.96% | -167.13% | 69.2% | 1135.01% | 408.16% | - |
| Net Income (Continuing) | 65.23M | 78.33M | -283.01M | -81.1M | 120.81M | 71.4M | 5.78M | -1.88M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.26 | 0.31 | -1.35 | -0.43 | 0.59 | 0.44 | -0.05 | -0.05 |
| EPS Growth % | -17.53% | 122.96% | -213.95% | -172.88% | 34.09% | 981.76% | 6.9% | - |
| EPS (Basic) | - | 0.31 | -1.35 | -0.43 | 0.64 | 0.50 | -0.05 | -0.05 |
| Diluted Shares Outstanding | 254.36M | 249.9M | 209.47M | 190.15M | 195.39M | 161.54M | 187.17M | 187.17M |
| Basic Shares Outstanding | 266.56M | 249.9M | 209.47M | 190.15M | 182.69M | 144M | 187.17M | 187.17M |
| Dividend Payout Ratio | - | - | - | - | - | 140.06% | 172.98% | - |
Quick answers to the most common questions about buying CLBT stock.
For fiscal year 2025, Cellebrite DI Ltd. (CLBT) reported total revenue of $475.7M. This represents a 176.8% increase compared to $171.9M in 2019.
Cellebrite DI Ltd. (CLBT) is profitable, generating $78.3M in net income for the fiscal year ending 2025 with a net profit margin of 16.5%.
Cellebrite DI Ltd. (CLBT) reported an operating income of $66.5M, resulting in an operating profit margin of 14.0%. This margin reflects the operational efficiency of the business before interest and taxes.
Cellebrite DI Ltd. (CLBT) generated $400.5M in gross profit for the year, representing a gross profit margin of 84.2%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Margin volatility and opaque net income
Growth Holding Near Eighteen Percent Pace
Based on reported quarterly figures, CLBT's revenue rose from $95.7M in 2024Q2 to $149.0M in 2026Q3, with year-over-year growth sustained between roughly 16% and 20% across the recent period, suggesting durable demand.
The consistency of growth in the high teens across multiple quarters suggests the subscription transition is supporting top-line momentum rather than relying on one-time hardware cycles. The absence of an acceleration trend, however, means the thesis rests on stability rather than inflection, and investors should monitor whether government and enterprise contract timing begins to flatten the curve.
Gross Margin Anchored Near Eighty-Four Percent
As reported in the quarterly income statements, CLBT's gross margin has held in an 80% to 86% band across ten quarters, implying pricing power consistent with a software-weighted revenue mix.
The narrow range of gross margin fluctuation suggests incremental delivery costs remain minimal relative to revenue, which is characteristic of a licensed digital analytics model. Quarter-to-quarter dips toward 80.8% in 2026Q2 may reflect hardware or services mix shifts, which warrants further investigation rather than being treated as a structural change.
Operating Leverage Largely Muted by Reinvestment
Based on reported figures, CLBT's operating margin moved between roughly 6% and 18% over the recent period, while SG&A remained near $58M to $62M in the latest quarters, indicating limited scaling efficiency.
Operating income has fluctuated more than gross profit, which suggests that sales and go-to-market spending absorbs much of the incremental gross profit generated by growth. This pattern appears consistent with a company deliberately reinvesting to defend its platform position, though it also limits near-term evidence of operating leverage that investors may expect from a software model.
Net Margin Exceeds Operating Margin Unexplained
According to reported financial statements, CLBT's net margin of 17.9% in 2026Q3 exceeded its operating margin of 18.0% only marginally, while in prior periods net margin diverged materially from operating margin, warranting closer scrutiny.
Net income has at times diverged sharply from operating income, including a large loss in 2024Q3 that the provided data does not explain, so the drivers of these swings cannot be confirmed from the supplied figures. Stock-based compensation of roughly $9M to $15M per quarter represents a meaningful non-cash cost, and the gap between operating and net results should be reconciled against tax and non-operating items before treating reported earnings as a clean signal.
Persistent Reinvestment May Cap Profitability
Based on reported figures, CLBT's operating margin has not sustained above roughly 18%, and SG&A and R&D together consume a large share of gross profit, which may limit earnings expansion if growth slows.
The bear case centers on whether the company's high gross margin is being largely absorbed by sales and R&D spending, leaving operating profitability modest relative to a software peer set. Peer operating margins vary widely, and if growth decelerates toward low-single digits, the fixed reinvestment base could compress margins faster than revenue, which investors should monitor closely.